Catalyst Wire Dossier Catalyst Wire Dossier

Bepreve

bepotastine besilate
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Bepreve, covering 2010-07-08 to 2019-08-06. Get the full timeline:

Most recent: Clinical Trial Update: Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis [Phase 4]

See pricing